Width: | 225px |
Class: | α1-Adrenergic receptor agonist; Antihypotensive agent; Vasopressor |
Cas Number: | 3600-87-1 |
Pubchem: | 43260 |
Drugbank: | DBMET00829 |
Unii: | S57K35I2FV |
Kegg: | C21521 |
Chebi: | 73248 |
Chembl: | 1076 |
Synonyms: | Deglymidodrine; ST-1059; 3,6-Dimethoxy-β-hydroxy-2-phenylethylamine |
Iupac Name: | 2-amino-1-(2,5-dimethoxyphenyl)ethanol |
C: | 10 |
H: | 15 |
N: | 1 |
O: | 3 |
Smiles: | COC1=CC(=C(C=C1)OC)C(CN)O |
Stdinchi: | 1S/C10H15NO3/c1-13-7-3-4-10(14-2)8(5-7)9(12)6-11/h3-5,9,12H,6,11H2,1-2H3 |
Stdinchikey: | VFRCNXKYZVQYLX-UHFFFAOYSA-N |
Desglymidodrine (developmental code name ST-1059) is the active metabolite of the prodrug antihypotensive agent midodrine.[1] [2] [3] It acts as a selective α1-adrenergic receptor agonist. Desglymidodrine is formed from midodrine via deglycination.
Desglymidodrine, also known as 3,6-dimethoxy-β-hydroxy-2-phenylethylamine, is a substituted phenethylamine derivative.
Midodrine's experimental log P is -0.5 and its predicted log P ranges from -0.49 to -0.95.[4] [5] The predicted log P of desglymidodrine ranges from -0.01 to 0.15.[6] [7]
An analogue of desglymidodrine is dimetofrine (3,5-dimethoxy-4,β-dihydroxy-N-methylphenethylamine).